The use of a hypoxic cell radiosensitizer AK-2123 gave no improvement in thermoradiotherapy combined with hydralazine

International Journal of Hyperthermia

Volumn 12, Issue 6, 1996, Pages 771-777

  Kozin, S V ^a,d,e   Hasegawa, T ^b   Kozina, L V ^d   Imamura, M ^a   Akagi, K ^a   Tanaka, Y ^a   Kagiya, V T ^c  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c HEALTH RESEARCH FOUNDATION   (Japan)

^d INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

AK 2123; Blood flow; Hydralazine; Thermoradiotherapy; Tumour growth delay

Indexed keywords

HYDRALAZINE; RADIOSENSITIZING AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEAT; HYPERTHERMIC THERAPY; HYPOXIC CELL; MOUSE; NONHUMAN; RADIOSENSITIVITY; RADIOTHERAPY; TUMOR;

EID: 0029822725     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739609027683     Document Type: Article

References (20)

1. Eighth International Conference on Chemical Modifiers of Cancer Treatment (Kyoto, Japan, 1993), Abstracts, 1993.
2. CHAPLIN, D. J., OLIVE, P. L., and DURAND, R. L., 1987, Intermittent blood flow in a murine tumor: Radiobiological effects. Cancer Research, 47, 597-601.
3. DEWHIRST, M. W., 1994, Future directions in hyperthermia biology. International Journal of Hyperthermia, 10, 339-345.
4. FIELD, S. B., BURNEY, I. A., NEEDHAM, S., MAXWELL, R. J., and GRIFFITHS, J. R., 1994, From hydralazine to CGRP to man? International Journal of Hyterthermia, 10, 451-455.
5. GERWECK, L. E., NYGAARD, T. G., and BURLETT, M., 1979, Response of cells to hyperthermia under acute and chronic hypoxic conditions. Cancer Research, 39, 966-972.
6. GERWECK, L. E., 1982, Effect of microenvironmental factors on the response of cells to single and fractionated heat treatments. National Cancer Institute Monograph, 61, 19-26.
7. HORSMAN, M. R., CHAPLIN, D. J., and OVERGAARD, J., 1990, Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells. Cancer Research, 50, 7430-7436.
8. HORSMAN, M. R., LINDEGAARD, J. C., and OVERGAARD, J., 1992, Interaction of hyperthermia and radiation in solid tumors in vivo. Radiation Research: A Twentieth-Century Perspective. Volume II: Congress Proceedings, edited by W. C. Dewey, M. Edington, R. J. M. Fry, E. J. Hall and G. F. Whitmore (San Diego, New York, Boston, London, Sydney, Tokyo and Toronto: Academic Press, Inc.), pp. 1033-1038.
9. HORSMAN, M. R. and OVERGAARD, J., 1992, Overcoming tumour radiation resistance resulting from acute hypoxia. European Journal of Cancer, 28A, 717-718.
10. KOZIN, S. V., HASEGAWA, T., HA-KAWA, S. K., AKAGI, K., and TANAKA, Y., 1994, Hydralazine at thermoradiotherapy: Tumor size and blood flow effects. International Journal of Radiation Oncology, Biology and Physics, 29, 505-510.
11. KOZIN, S. V., VOLENEC, K., ZAITSEV, A. V, BORISOV, M. B., and YARMONENKO, S. P., 1992, Hydralazine for enhancement of thermoradiotherapy efficacy. Radiosensitization Newsletter, 11(4), 2-4.
12. KOZIN, S. V., ZAITSEV, A. V., and YARMONENKO, S. P., 1996, Antitumor effect of irradiation followed by hyperglycemia and hyperthermia: The dependence on tumor size and blood flow. International Journal of Hyperthermia, 12, 147-156.
13. KUNUGITA, N., NORIMURA, T., and TSUCHIYA, T., 1993, Experimental study of the effects of AK-2123 in multimodal treatment. Eighth International Conference on Chemical Modifiers of Cancer Treatment (Kyoto, Japan, 1993), pp. 231-232.
14. OLESON, J. R., CALDERWOOD, S. K., COUGHLIN, C. T., DEWHIRST, M. W., GERWECK, L. E., GIBBS, F. A. and KAPP, D. S., 1988, Biological and clinical aspects of hyperthermia in cancer therapy. American Journal of Clinical Oncology (CCT), 11, 368-380.
15. OSINSKY, S. and KELLEHER, D. K., 1992, Changes of laser Doppler flowmetry in rat tumors following AK-2123 application (preliminary communication). Radiosensitization Newsletter, 11(3), 2-4.
16. OSINSKY, S. P., BUBNOVSKAYA, L. N., and GANUSEVICH, I. I., 1994, In vivo thermochemosensitizing activity and pathophysiological effects of hypoxic radiosensitizer AK-2123. Experimental Oncology, 16, 61-66.
17. OVERGAARD, J., 1989, The current and potential role of hyperthermia in radiotherapy. International Journal of Radiation Oncology, Biology and Physics, 16, 535-549.
18. OVERGAARD, J., GRAU, C., LINDEGAARD, J.C., and HORSMAN, M.R., 1991, The potential of using hyperthermia to eliminate radioresistant hypoxic cells. Radiotherapy and Oncology, (Suppl) 20, 113-116.
19. TANAKA, M., and KAGIYA, V. T., 1991, Effect of hydralazine as a vasodilator on pharmokinetics of AK-2123 and efficacy of radiation treatment in vivo. 7th International Conference on Chemical Modifiers of Cancer Treatment (Clearwater, Florida, USA, 1991), pp. 60-61.
20. YARMONENKO, S. P., and KOZIN, S. V., 1992, Radiobiological approaches to enhancement of thermoradiotherapy efficacy. Radiation Research: A Twentieth-Century Perspective, Volume II: Congress Proceedings, edited by W. C. Dewey, M. Edington, R. J. M. Fry, E. J. Hall and G. F. Whitmore (San Diego, New York, Boston, London, Sydney, Tokyo and Toronto: Academic Press, Inc.), pp. 1016-1020.